The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients.
We assessed the impact of chest CT body composition parameters on outcomes and disease severity at hospital presentation of COVID-19 patients, focusing also on the possible mediation of body composition in the relationship between age and death in these patients. Chest CT scans performed at hospital...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0251768 |
id |
doaj-0f9c9fd0dcb7408d8c3a9f9394c68f0f |
---|---|
record_format |
Article |
spelling |
doaj-0f9c9fd0dcb7408d8c3a9f9394c68f0f2021-05-30T04:30:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01165e025176810.1371/journal.pone.0251768The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients.Giulia BesuttiMassimo PellegriniMarta OttoneMichele CantiniJovana MilicEfrem BonelliGiovanni DolciGiulia CassoneGuido LigabueLucia SpaggiariPierpaolo PattaciniTommaso FasanoSimone CanoviMarco MassariCarlo SalvaraniGiovanni GuaraldiPaolo Giorgi RossiReggio Emilia COVID-19 Working GroupWe assessed the impact of chest CT body composition parameters on outcomes and disease severity at hospital presentation of COVID-19 patients, focusing also on the possible mediation of body composition in the relationship between age and death in these patients. Chest CT scans performed at hospital presentation by consecutive COVID-19 patients (02/27/2020-03/13/2020) were retrospectively reviewed to obtain pectoralis muscle density and total, visceral, and intermuscular adipose tissue areas (TAT, VAT, IMAT) at the level of T7-T8 vertebrae. Primary outcomes were: hospitalization, mechanical ventilation (MV) and/or death, death alone. Secondary outcomes were: C-reactive protein (CRP), oxygen saturation (SO2), CT disease extension at hospital presentation. The mediation of body composition in the effect of age on death was explored. Of the 318 patients included in the study (median age 65.7 years, females 37.7%), 205 (64.5%) were hospitalized, 68 (21.4%) needed MV, and 58 (18.2%) died. Increased muscle density was a protective factor while increased TAT, VAT, and IMAT were risk factors for hospitalization and MV/death. All these parameters except TAT had borderline effects on death alone. All parameters were associated with SO2 and extension of lung parenchymal involvement at CT; VAT was associated with CRP. Approximately 3% of the effect of age on death was mediated by decreased muscle density. In conclusion, low muscle quality and ectopic fat accumulation were associated with COVID-19 outcomes, VAT was associated with baseline inflammation. Low muscle quality partly mediated the effect of age on mortality.https://doi.org/10.1371/journal.pone.0251768 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Giulia Besutti Massimo Pellegrini Marta Ottone Michele Cantini Jovana Milic Efrem Bonelli Giovanni Dolci Giulia Cassone Guido Ligabue Lucia Spaggiari Pierpaolo Pattacini Tommaso Fasano Simone Canovi Marco Massari Carlo Salvarani Giovanni Guaraldi Paolo Giorgi Rossi Reggio Emilia COVID-19 Working Group |
spellingShingle |
Giulia Besutti Massimo Pellegrini Marta Ottone Michele Cantini Jovana Milic Efrem Bonelli Giovanni Dolci Giulia Cassone Guido Ligabue Lucia Spaggiari Pierpaolo Pattacini Tommaso Fasano Simone Canovi Marco Massari Carlo Salvarani Giovanni Guaraldi Paolo Giorgi Rossi Reggio Emilia COVID-19 Working Group The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients. PLoS ONE |
author_facet |
Giulia Besutti Massimo Pellegrini Marta Ottone Michele Cantini Jovana Milic Efrem Bonelli Giovanni Dolci Giulia Cassone Guido Ligabue Lucia Spaggiari Pierpaolo Pattacini Tommaso Fasano Simone Canovi Marco Massari Carlo Salvarani Giovanni Guaraldi Paolo Giorgi Rossi Reggio Emilia COVID-19 Working Group |
author_sort |
Giulia Besutti |
title |
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients. |
title_short |
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients. |
title_full |
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients. |
title_fullStr |
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients. |
title_full_unstemmed |
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients. |
title_sort |
impact of chest ct body composition parameters on clinical outcomes in covid-19 patients. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2021-01-01 |
description |
We assessed the impact of chest CT body composition parameters on outcomes and disease severity at hospital presentation of COVID-19 patients, focusing also on the possible mediation of body composition in the relationship between age and death in these patients. Chest CT scans performed at hospital presentation by consecutive COVID-19 patients (02/27/2020-03/13/2020) were retrospectively reviewed to obtain pectoralis muscle density and total, visceral, and intermuscular adipose tissue areas (TAT, VAT, IMAT) at the level of T7-T8 vertebrae. Primary outcomes were: hospitalization, mechanical ventilation (MV) and/or death, death alone. Secondary outcomes were: C-reactive protein (CRP), oxygen saturation (SO2), CT disease extension at hospital presentation. The mediation of body composition in the effect of age on death was explored. Of the 318 patients included in the study (median age 65.7 years, females 37.7%), 205 (64.5%) were hospitalized, 68 (21.4%) needed MV, and 58 (18.2%) died. Increased muscle density was a protective factor while increased TAT, VAT, and IMAT were risk factors for hospitalization and MV/death. All these parameters except TAT had borderline effects on death alone. All parameters were associated with SO2 and extension of lung parenchymal involvement at CT; VAT was associated with CRP. Approximately 3% of the effect of age on death was mediated by decreased muscle density. In conclusion, low muscle quality and ectopic fat accumulation were associated with COVID-19 outcomes, VAT was associated with baseline inflammation. Low muscle quality partly mediated the effect of age on mortality. |
url |
https://doi.org/10.1371/journal.pone.0251768 |
work_keys_str_mv |
AT giuliabesutti theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT massimopellegrini theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT martaottone theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT michelecantini theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT jovanamilic theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT efrembonelli theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT giovannidolci theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT giuliacassone theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT guidoligabue theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT luciaspaggiari theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT pierpaolopattacini theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT tommasofasano theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT simonecanovi theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT marcomassari theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT carlosalvarani theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT giovanniguaraldi theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT paologiorgirossi theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT reggioemiliacovid19workinggroup theimpactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT giuliabesutti impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT massimopellegrini impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT martaottone impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT michelecantini impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT jovanamilic impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT efrembonelli impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT giovannidolci impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT giuliacassone impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT guidoligabue impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT luciaspaggiari impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT pierpaolopattacini impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT tommasofasano impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT simonecanovi impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT marcomassari impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT carlosalvarani impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT giovanniguaraldi impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT paologiorgirossi impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients AT reggioemiliacovid19workinggroup impactofchestctbodycompositionparametersonclinicaloutcomesincovid19patients |
_version_ |
1721421039863332864 |